Home » UPC decisions » Luxembourg Court of Appeal » CoA, January 9, 2025, order concerning public access to the register, UPC_CoA_480/2024; UPC_CoA_481/2024

CoA, January 9, 2025, order concerning public access to the register, UPC_CoA_480/2024; UPC_CoA_481/2024

4 min Reading time

Key takeaways

  • This right is enshrined in Rule 262.1(b) RoP and promotes transparency and trust in the court system.
  • The Court of Appeal emphasized that this right allows the public to understand court decisions and scrutinize the court’s handling of disputes.
  • The Appellant argued against public access, claiming it wouldn’t enhance public understanding, while the Respondent argued for transparency and public scrutiny of the court’s reasoning.
  • The integrity of proceedings must be balanced against the public interest.
  • Public’s interest in understanding the decision-making process outweighs potential harm to the integrity of proceedings
  • Rule 262.1(b) RoP requires applicants to explain their purpose for seeking access and how it aligns with the general interest.
  • Citing Ocado v Autostore, the Court highlighted the need to identify specific documents and explain the purpose for seeking access.
  • The Respondent’s request was deemed reasonable as it aimed to understand the CFI’s decision based on the presented arguments and evidence, aligning with transparency.
  • Once the CFI issues a decision, the need to protect the integrity of those proceedings diminishes.
  • The Court reasoned that public discussion is inevitable during appeals and subsequent proceedings, justifying access to CFI records.
  • The decision clarified that even in cases involving provisional measures (R.206 RoP), public scrutiny should not be hindered.

Division

Court of Appeal

UPC number

UPC_CoA_480/2024; UPC_CoA_481/2024

Type of proceedings

Appeal

Parties

  • Appellant (Applicant in the main proceedings): Abbott Diabetes Care Inc. (‘Abbott’)
  • Respondent (Applicant for access to the register): Powell Gilbert LLP (‘Powell Gilbert’)
  • Defendants in the main proceedings: Sibio Technology Limited and Umedwings Netherlands B.V. (‘Sibionics’)

Patent(s)

EP 2 713 879 and EP 3 831 283

Jurisdictions

Unified Patent Court

Body of legislation / Rules

  • Rule 262.1(b) RoP
  • Rule 206 RoP
  • Article 45 UPCA

Was the article helpful?


Categories


Tags

Stay in the loop

Never miss a beat by subscribing to the email newsletter. Please see our Privacy Policy.

* = Required field